IL-1 Gene Screening Identifies Coronary Artery Disease Susceptibility
This article was originally published in The Gray Sheet
Executive Summary
Medical Science Systems, Inc. says it will pursue corporate partnerships to commercialize a test for the identification of a genetic risk factor for coronary artery disease.
You may also be interested in...
Interleukin Restenosis Susceptibility Test Launch Expected In 2000
Interleukin Genetics is seeking a diagnostics partner to market and distribute its development-stage genetic screening test for determining a patient's susceptibility to restenosis following angioplasty and stenting.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”